Jason Su1,
1Department of Radiology,
Stanford University, Stanford, CA, United States; 2Department of
Neuroradiology, Technische Universitaet Dresden, Dresden, Germany; 3Robarts
Research Institute, University of Western Ontario, London, Ontario, Canada; 4Department
of Diagnostic Radiology & Nuclear Medicine, University of Western
Ontario, London, Ontario, Canada; 5Department of Clinical
Neurological Sciences, University of Western Ontario, London, Ontario,
Canada; 6Brown University, Providence, RI, United States
Using the whole-brain, myelin-selective MR method, multi-component Driven Equilibrium Single Pulse Observation of T1 and T2 (mcDESPOT), we examined the development of disease in a cohort of patients and controls at baseline and 1 year; the first longitudinal application of this new MR methodology. Derived quantitative measures were shown to be highly sensitive to changes in the health of the brain, having statistically significant changes in MS patients compared to normals, while the coarse EDSS clinical disability score was unable to detect a change. These measures are promising new markers for assessing the course of disease.